GlassScriptPhysician profile
Claire Johnson
NPI 1285324921
$7,711.41
in general payments reported to CMS, 2019-2025
52 companies · $2,902 in 2025
The $2,902 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,413 · 2024: $3,396 · 2025: $2,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,634 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,634.42 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $939.77 | 2023-2025 | |
| Ucb, INC. | $876.46 | 2023-2025 | Briviact, Rystiggo, Fintepla |
| Acadia Pharmaceuticals INC | $421.17 | 2023-2025 | Nuplazid, Daybue |
| Teva Pharmaceuticals USA, INC. | $336.38 | 2023-2025 | Austedo Xr, Austedo Xr |
| Biogen, INC. | $305.56 | 2023-2025 | Vumerity, Tysabri, Skyclarys |
| Eisai INC. | $276.56 | 2023-2025 | |
| Pfizer INC. | $262.90 | 2024-2025 | |
| Lundbeck LLC | $203.58 | 2023-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $203.50 | 2023-2025 | Emgality, Reyvow, Amyvid |
| Alexion Pharmaceuticals, INC. | $200.70 | 2023-2025 | Ultomiris, Soliris |
| Grifols USA, LLC | $199.92 | 2024-2025 | Gamunex-C |
| Jazz Pharmaceuticals INC. | $195.37 | 2023-2025 | Epidiolex |
| Genentech USA, INC. | $187.58 | 2023-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Merz Pharmaceuticals, LLC | $181.59 | 2024 | Xeomin |
| Kyowa Kirin, INC. | $171.54 | 2023-2025 | Nourianz |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $168.33 | 2023-2025 | Octagam Immune Globulin (Human), Panzyga |
| Ge Healthcare | $160.18 | 2023-2025 | |
| Tg Therapeutics, INC. | $159.69 | 2023-2025 | |
| Genzyme Corporation | $159.36 | 2024 | |
| Celgene Corporation | $153.14 | 2023-2025 | Zeposia |
| Vanda Pharmaceuticals INC. | $149.61 | 2025 | Ponvory |
| Emd Serono, INC. | $137.17 | 2024-2025 | Mavenclad |
| Neurocrine Biosciences, INC. | $125.08 | 2023-2025 | Ingrezza, Ongentys |
| Csl Behring | $112.58 | 2023-2025 | Hizentra, Privigen |
| Novartis Pharmaceuticals Corporation | $104.00 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $100.25 | 2023-2024 | Aptiom |
| Janssen Biotech, INC. | $97.95 | 2025 | |
| Tanabe Pharma America, INC. | $83.55 | 2023-2025 | Radicava |
| Azurity Pharmaceuticals, INC. | $82.30 | 2024-2025 | Horizant |
| Mdd US Operations, LLC | $75.20 | 2024 | Gocovri |
| Ipsen Biopharmaceuticals, INC | $74.92 | 2023-2025 | Dysport |
| Ani Pharmaceuticals, INC. | $74.03 | 2024-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $70.65 | 2025 | Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $61.49 | 2023-2025 | Hyqvia |
| Livanova USA, INC. | $58.39 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Alnylam Pharmaceuticals INC. | $57.21 | 2023-2024 | Onpattro |
| Sk Life Science, INC. | $54.49 | 2023 | |
| Medtronic, INC. | $49.00 | 2025 | Intellis Adaptivestim |
| Argenx US, INC. | $45.62 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Otsuka America Pharmaceutical, INC. | $44.70 | 2023-2025 | Rexulti |
| Kedrion Biopharma, INC. | $42.98 | 2024 | Rhogam Ultra-Filtered Plus, Kedrab, Albuked |
| Acorda Therapeutics, INC | $38.52 | 2023-2024 | Inbrija |
| Averitas Pharma INC. | $29.56 | 2024 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $27.16 | 2024 | Zeposia |
| Corium, LLC | $26.43 | 2023 | Adlarity |
| Amgen INC. | $26.23 | 2025 | Uplizna |
| Aprecia Pharmaceuticals, LLC | $19.52 | 2023 | Spritam |
| Springworks Therapeutics, INC. | $19.43 | 2025 | Gomekli |
| Sandoz INC. | $16.51 | 2023 | |
| Ns Pharma, INC. | $16.13 | 2025 | Viltepso |
| Catalyst Pharmaceuticals, INC. | $13.83 | 2024 | |
| Tonix Medicines, INC. | $13.64 | 2025 | Zembrace Symtouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.